Provider: View Press Release
Type: Link
Title: GSK publishes Prospectus and Circular for proposed demerger of its Consumer Healthcare business to form Haleon | GSK
Description: The Circular is available at www.gsk.com/demerger and the Prospectus is available at www.haleon.com
Provider: View Press Release
Type: Link
Title: GSK to acquire clinical-stage biopharmaceutical company Affinivax, Inc. | GSK
Description: Supports development of a strong portfolio of innovative vaccines and specialty medicines
Provider: View Press Release
Type: Link
Title: ViiV Healthcare announces marketing approval by Japan’s Ministry of Health, Labour and Welfare for Vocabria (cabotegravir) used in combination with Rekambys (rilpivirine) | GSK
Description: Long-acting treatment enables people living with HIV to reduce the days they receive treatment.
Provider: View Press Release
Type: Link
Title: GSK announces further appointments to Designate Haleon Board | GSK
Description: Demerger and listing of Haleon expected in July 2022
Provider: View Press Release
Type: Link
Title: China approves Cervarix two-dose vaccine schedule for girls aged 9 to 14 against certain types of cancer-causing human papillomavirus | GSK
Description: China’s National Medical Products Administration has approved a two-dose vaccine schedule for Cervarix in girls aged between 9 to 14 years.
Provider: View Press Release
Type: Link
Title: ViiV Healthcare commits to grant voluntary licence for patents relating to cabotegravir long-acting for PrEP to Medicines Patent Pool | GSK
Description: ViiV Healthcare and MPP are actively negotiating voluntary licensing terms to help widen access to innovative HIV prevention measure